Filter
6528
Filtered Results: 6528
Text search:
Blood
Featured
Recommendations
619
New Publications
1772
Language
Document type
No document type
3821
Studies & Reports
886
Guidelines
871
Manuals
316
Fact sheets
177
Training Material
154
Strategic & Response Plan
148
Situation Updates
47
Infographics
40
Brochures
28
Resource Platforms
21
Videos
11
Online Courses
6
Dashboards/Maps
1
App
1
Countries / Regions
India
421
Global
256
Kenya
176
Sierra Leone
168
South Africa
155
Liberia
148
Ethiopia
139
Nigeria
137
Nepal
126
Uganda
123
Tanzania
106
Rwanda
93
Ghana
91
Latin America and the Carribbean
90
Malawi
89
Zambia
88
Western and Central Europe
79
Bangladesh
78
Africa
73
Philippines
67
Myanmar / Burma
64
Congo, Democratic Republic of
60
Namibia
56
Ukraine
53
Lesotho
50
Syria
47
Indonesia
44
Zimbabwe
43
Senegal
42
Guinea
39
Cambodia
37
Burkina Faso
35
South–East Asia Region
35
Russia
35
West and Central Africa
33
Mozambique
32
Germany
31
Venezuela
31
Brazil
30
Asia
30
Eastern Europe
28
Haiti
27
Eswatini/ Swaziland
25
Cameroon
24
East and Southern Africa
24
Botswana
22
Yemen
20
South Sudan
18
Eastern Europe and Central Asia
18
Mali
17
Middle East and North Africa
17
USA
15
Pakistan
15
Benin
15
Afghanistan
14
El Salvador
13
Côte d’Ivoire / Ivory Coast
11
Madagascar
11
Western Pacific Region
11
Argentina
10
Peru
10
Colombia
10
Angola
10
Paraguay
10
Albania
9
Tajikistan
9
Georgia
9
North America
9
Niger
8
Chad
8
Mexico
8
Sri Lanka
8
Chile
8
United Kingdom
8
Sudan
7
Bolivia
7
Southern Africa
7
Moldova
7
Somalia
6
Lebanon
6
Thailand
6
China
6
Central African Republic
6
Palestine
6
Vietnam
6
Guinea-Bissau
5
Iraq
5
Jordan
5
Armenia
5
Laos
5
Spain
5
Saudi Arabia
4
Turkey
4
Egypt
4
Papua New Guinea
4
North Macedonia
4
Burundi
4
Togo
3
Honduras
3
Ecuador
3
Libya
3
Bhutan
3
Poland
3
Iran
3
France
3
Portugal
3
Gambia
2
Hungary
2
Guatemala
2
Other region
2
Congo-Brazzaville
2
Timor Leste/ East Timor
2
Kyrgyzstan
2
Kazakhstan
2
Belarus
2
Bosnia and Herzegovina
2
Morocco
1
Mauritania
1
Switzerland
1
Serbia
1
Greece
1
Bahamas
1
Nicaragua
1
Fiji
1
Solomon Islands
1
Djibouti
1
Mongolia
1
Qatar
1
Bulgaria
1
Estonia
1
Romania
1
Lithuania
1
Slovakia
1
Uzbekistan
1
Australia
1
Gabon
1
Uruguay
1
Turkmenistan
1
Jamaica
1
Japan
1
Belgium
1
Maldives
1
Mauritius
1
Tunisia
1
Azerbaijan
1
French Guyana
1
Israel
1
Latvia
1
United Arab Emirates
1
Authors & Publishers
Publication Years
Category
Countries
2554
Clinical Guidelines
713
Public Health
417
Women & Child Health
354
Key Resources
198
Capacity Building
183
Pharmacy & Technologies
101
Annual Report MEDBOX
1
Toolboxes
HIV
534
COVID-19
466
Mental Health
374
Ebola
307
TB
282
NCDs
273
Caregiver
223
Rapid Response
208
NTDs
189
AMR
158
Planetary Health
148
Pharmacy
128
Refugee
116
Conflict
112
Zika
76
Global Health Education
70
Disability
65
Specific Hazards
43
Natural Hazards
40
Cholera
33
Social Ethics
29
Health Financing Toolbox
24
Polio
20
Front Chem. 2021; 9: 622286.
Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out health interventions in emergency and humanitarian r...
Discrete typing units of Trypanosoma cruzi: Geographical and biological distribution in the Americas
Chagas disease caused by Trypanosoma cruzi is a public health issue in Latin America. This highly diverse parasite is divided into at least seven discrete typing units (DTUs) TcI-TcVI and Tcbat. Some DTUs have been associated with geographical distribution in epidemiological scenarios and clinical m...
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 117: e200460, 2022
Integrating the multiple dimensions of the problem into a coherent approach adapted to field realities and needs represents an immense challenge, but the payoff is more effective and sustainable experiences, with higher social awareness...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
Two adjectives raise an issue for communicators working on Chagas disease (CD): “invisible and silent”. Two adjectives that can be ascribed to other neglected tropical diseases (NTD), but which are part of the essence of CD. Bringing CD out of its situation of neglect and oblivion is a mission e...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
This guideline for the prevention and control of chikungunya fever
(CF) is intended for use by all peripheral health workers in the Region and
is based on the strategy outlined above. This document will focus mainly
on preventing, predicting and detecting outbreaks, and after detection,
investig...
Access to health workers who are fit for purpose, motivated and protected is a fundamental force of health service delivery and the achievement of universal health coverage and the health and health-related Sustainable Development Goals. Data and knowledge of the distribution, skill mix and future d...
At the forefront of DNDi’s efforts to develop new treatments is the need to understand the realities and treatment needs of patients and health care staff in the field. The ultimate goal for human African trypanosomiasis (HAT) is a truly simplified
treatment which can be orally administered, impl...
Urogenital schistosomiasis is a common neglected tropical disease in many rural communities in African countries, with patches of infection in the Eastern Mediterranean Region. Globally, an estimated 239 million people are currently infected, with burden estimated at more than 3.5 million disability...
Schistosomiasis is widely recognized as a disease that is socially determined. An understanding of the social and behavioural factors linked to disease transmission and control should play a vital role in designing policies and strategies for schistosomiasis prevention and control. To this must be a...
Theodor Bilharz, a German professor of anatomy and chief of surgery at the Kasr El Ani Hospital of Cairo from 1850, first identified an infective organism, Distomum hematobium in 1851, which was renamed Schistosoma haematobium in 1858. It arose from a cestode worm, Hymenoleptis nana, lying in the sm...
The sub-Saharan African region, carries 90% of the over 250 million cases of schistosomiasis occurring worldwide. In this region, after Nigeria, Tanzania is second country having the highest cases of schistosomiasis and approximately 51.5%0 of the Tanzanian population is either exposed or live in ar...
Schistosomiasis is a neglected tropical disease of global medical and veterinary importance. As efforts to eliminate schistosomiasis as a public health problem and interrupt transmission gather momentum, the potential zoonotic risk posed by livestock Schistosoma species via viable hybridisation in s...
The aim of this toolkit is to guide countries on how to best estimate their current burden of dengue by combining existing data from dengue surveillance systems with on-going research efforts to measure the community burden
of dengue.
These country profiles present progress on implementation of policy recommendations of the Global Action Plan on Physical Activity (GAPPA) 2018-2030 in each country. They also present an estimate of the cost to health systems of not taking action to improve physical activity levels and reinforce th...
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
